Guidance

Regenerative medicine: government response to Science and Technology Committee inquiry

Document setting out how the government supports the regenerative medicine sector.

• From: Department of Health and Social Care
• Published: 23 August 2017

Documents

Government Response to the House of Commons Science and Technology Committee Inquiry into Regenerative Medicine (print version)

Ref: ISBN 978-1-5286-0006-4, Cm. 9491

PDF, 749 KB, 16 pages

Order a copy

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Government Response to the House of Commons Science and Technology Committee Inquiry into Regenerative Medicine (web accessible version)

Ref: Cm. 9491

PDF, 294 KB, 13 pages

Order a copy

Details

This document is the government’s response to the House of Commons Science and Technology Committee report of 28 April 2017.

Regenerative medicine involves replacing or regenerating tissues or organs in the human body, in order to restore or establish normal function. Examples include stem cell therapy, gene therapy and tissue engineering.

The response shows how the government is working to create an integrated environment that allows the delivery of therapies and supports the development of a world-leading regenerative medicine industry in the UK.

Published 23 August 2017